Treatment News : Syringes With Less 'Dead Space' May Reduce HIV and Hep C Transmission

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » March 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


March 2, 2013

Syringes With Less 'Dead Space' May Reduce HIV and Hep C Transmission

Syringes designed to have less "dead space," retaining a smaller amount of fluid after the plunger has been depressed, could help stem the HIV and hepatitis C epidemics among the world's 16 million injection drug users, The Atlantic reports. Reviewing the available evidence on the topic, investigators published a review in The International Journal of Drug Policy and used the platform to advocate for wider use of low-dead-space syringes, even before the completion of rigorous—and likely expensive—studies for which they also advocate.

High-dead-space needles retain fluid in the tip of the syringe, hub of the needle and in the needle. Low-dead-space needles, on the other hand, do not have a detachable needle, and after the plunger is fully depressed they only retain fluid in the needle. On average, low-dead-space syringes retain only 2 microliters of fluid, compared with 84 microliters in high-dead-space syringes.

Laboratory experiments simulating injection drug use followed by a rinse of the syringes with water have found that low-dead-space syringes retain 0.1 percent of the blood compared with high-dead-space syringes. The study authors write that, following injection into someone with a viral load between 2,000 and 1 million, the high-dead-space syringes could carry "multiple copies of HIV," while the "low-dead-space syringes would retain even a single copy only a fraction of the time."

The authors also cite a recent laboratory study that suggested low-dead-space syringes could help curb the hepatitis C epidemic. In the study, hep C could survive for only one day in a low-dead-space syringe, but for up to 60 days in a high-dead-space syringe.

To read the Atlantic report, click here.

To read the study, click here.

Search: Low-dead-space-syringe, HIV, hepatitis C, transmission, high-dead-space, injection drug users, The Atlantic, The International Journal of Drug Policy.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.